Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Oncology Letters|May 23, 2017
FBP1 expression is associated with basal-like breast carcinomaLei Shi, Chunbo Zhao, Haihong Pu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 29, 2021
MiR-342-3p inhibits LCSC oncogenicity and cell stemness through HDAC7/PTEN axisChunlin Xu, Weiwei Sun, Jinglei Liu, et al.
Pathology, Research and Practice|April 19, 2023
Circ_RBM23 knockdown suppresses chemoresistance, proliferation, migration and invasion of sorafenib-resistant HCC cells through miR-338-3p/RAB1B axisChunlin Xu, Weiwei Sun, Jinglei Liu, et al.
Critical Reviews in Oncology/Hematology|March 2, 2025
Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancerLijun Li, Haihong Pu, Xiaoxin Zhang, et al.
Frontiers in Oncology|February 8, 2021
Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune MicroenvironmentYanbin Zhao, Minghui Zhang, Haihong Pu, et al.
Frontiers in Immunology|March 11, 2022
CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung AdenocarcinomaMinghui Zhang, Jianli Ma, Qiuyue Guo, et al.
Frontiers in Oncology|January 11, 2020
An Immune-Related Signature Predicts Survival in Patients With Lung AdenocarcinomaMinghui Zhang, Kaibin Zhu, Haihong Pu, et al.
World Journal of Surgical Oncology|November 27, 2015
Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinomaHaihong Pu, Qingyuan Zhang, Chunbo Zhao, et al.
Oncotarget|April 22, 2017
Expression of PD-L1 and prognosis in breast cancer: a meta-analysisMinghui Zhang, Houbin Sun, Shu Zhao, et al.
Pathology Oncology Research : POR|July 27, 2017
VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast CancerHaihong Pu, Qingyuan Zhang, Chunbo Zhao, et al.
Pageof 2